Search
for
Sort by
Research 241–270 of 1000+
- Il-10 family members as novel responders to genotoxic stress
- Effect of transcranial electrical stimulation on markers of immunosuppression in patients with COVID-19
- Telogen effluvium: a sequela of COVID‐19
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Telogen effluvium associated with COVID‐19 infection
- Alopecia and grey hair are associated with COVID‐19 Severity
- COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis
- Alopecia areata following COVID-19 vaccine: a systematic review
- Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Not just thinning: A case of alopecia universalis after mild COVID-19
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- SARS-CoV-2 Infection and COVID-19 Vaccination Associated with Post-Acute Alopecia: Prevalence, Clinical Patterns, and Determinants Among Saudi Adults
- Stem cell therapy alleviates hair loss caused by COVID-19 vaccination
- Greater susceptibility to telogen effluvium in the setting of severe COVID-19 infection: findings from a retrospective cohort study
- Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
- Telogen effluvium in covid-19 patients: a cross-sectional survey
- Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management.
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- The Incidence of Alopecia Areata in a COVID-19-Vaccinated Population: A Single-Center Review
- Telogen effluvium and COVID-19: a cross-sectional study.
- LSO-072 Comparison of COVID-19 vaccination with influenza vaccination in Korean patients with systemic lupus erythematosus: perception, adverse events, and flares from the CIVIL study
- 222 Severe COVID-19 infection predisposes patients to greater burden of hair loss
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- Hair loss after covid 19 - case series
- Telogen Effluvium and Trichodynia in Different Severity Groups of Post COVID-19 Patients
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Telogen Effluvium in Patients recovering from COVID-19